NCT05084430 2026-01-22Study of Pembrolizumab and M032 (NSC 733972)University of Alabama at BirminghamPhase 1/2 Recruiting28 enrolled
NCT02430363 2016-02-24Evaluation Of The Treatment Effectiveness Of Glioblastoma / Gliosarcoma Through The Suppression Of The PI3K/Akt Pathway In Compared With MK-3475Medical Research CouncilPhase 1/2 Unknown58 enrolled